ANDREA KESSLER: Open Payments
NPI 1205065513 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 10 payments from 7 companies in 2025. Trend: 2023 $519 · 2024 $691 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $150 |
| Ascendis Pharma Endocrinology Inc | 2 | $143 |
| Sequel Med Tech, LLC | 1 | $121 |
| BETA BIONICS, INC. | 1 | $84 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| Dexcom, Inc. | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
Products named: OMNIPOD, Yorvipath, TWIIST, iLet Bionic Pancreas, GVOKE HYPOPEN, Dexcom G6 Transmitter, TZIELD.
Industry payments across FL — which companies pay providers there.
